Munich - Delayed Quote EUR
Cipher Pharmaceuticals Inc (PHE.MU)
At close: October 22 at 8:02 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
22,159.00
21,162.00
20,675.00
21,943.00
21,607.00
--
Cost of Revenue
4,192.00
4,069.00
3,992.00
3,684.00
3,057.00
--
Gross Profit
17,967.00
17,093.00
16,683.00
18,259.00
18,550.00
--
Operating Expense
7,200.00
7,060.00
5,633.00
5,200.00
6,386.00
--
Operating Income
10,767.00
10,033.00
11,050.00
13,059.00
12,164.00
--
Net Non Operating Interest Income Expense
2,254.00
1,870.00
464.00
-80.00
-291.00
--
Other Income Expense
-735.00
778.00
-35.00
-1,920.00
-5,337.00
--
Pretax Income
12,286.00
12,681.00
11,479.00
11,059.00
6,536.00
--
Tax Provision
-10,318.00
-7,702.00
-15,157.00
3,301.00
2,150.00
--
Net Income Common Stockholders
22,604.00
20,383.00
26,636.00
7,758.00
4,549.00
--
Diluted NI Available to Com Stockholders
22,604.00
20,383.00
26,636.00
7,758.00
4,549.00
--
Basic EPS
0.92
0.82
1.05
0.29
0.17
--
Diluted EPS
0.90
0.80
1.03
0.29
0.17
--
Basic Average Shares
24,417.43
25,004.84
25,376.29
26,597.84
27,025.03
--
Diluted Average Shares
24,864.40
25,422.20
25,799.16
26,830.02
27,365.12
--
Total Expenses
11,392.00
11,129.00
9,625.00
8,884.00
9,443.00
--
Net Income from Continuing & Discontinued Operation
22,604.00
20,383.00
26,636.00
7,758.00
4,549.00
--
Normalized Income
23,228.75
19,916.20
26,661.83
9,104.90
7,967.41
--
Interest Income
2,254.00
1,870.00
464.00
12.00
32.00
--
Interest Expense
--
--
--
92.00
323.00
965.00
Net Interest Income
2,254.00
1,870.00
464.00
-80.00
-291.00
--
EBIT
10,767.00
10,033.00
11,050.00
13,059.00
6,859.00
--
EBITDA
11,890.00
11,260.00
12,039.00
13,760.00
8,064.00
--
Reconciled Cost of Revenue
4,192.00
4,069.00
3,992.00
3,684.00
3,057.00
--
Reconciled Depreciation
1,123.00
1,227.00
989.00
701.00
1,205.00
--
Net Income from Continuing Operation Net Minority Interest
22,604.00
20,383.00
26,636.00
7,758.00
4,386.00
--
Total Unusual Items Excluding Goodwill
-735.00
778.00
-35.00
-1,920.00
-5,337.00
--
Total Unusual Items
-735.00
778.00
-35.00
-1,920.00
-5,337.00
--
Normalized EBITDA
12,625.00
10,482.00
12,074.00
15,680.00
13,401.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-110.25
311.20
-9.17
-573.10
-1,755.59
--
12/31/2019 - 1/4/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade